Siron Clinical will be participating in the World Orphan Drug Congress Europe 2025, held from 27 to 29 October at the RAI Congress Centre in Amsterdam.
This global gathering brings together leading voices in the orphan drug and rare disease ecosystem, scientists, biotech and pharma executives, regulators, payers, patient advocates, and public health authorities, to accelerate innovation, collaboration, and access in rare disease therapeutics.
At Siron Clinical, we believe that meaningful progress in rare disease requires bridging both scientific excellence and translational pathways. The Congress offers precisely that forum: a platform for rigorous science, strategic partnering, and policy dialogue across the entire orphan drug value chain.
Why This Congress Matters to Siron Clinical
The World Orphan Drug Congress is the most established global meeting dedicated to orphan drugs and rare disease innovation, with a comprehensive agenda spanning regulatory trends, real‑world evidence, patient centricity, cell & gene therapy, market access, financing models, and more.
Over 2,000 attendees, 250+ speakers, and 130 exhibitors are expected to participate in this year’s event.
For Siron Clinical, this is more than an appearance; it is an opportunity to deepen connections across the rare disease ecosystem, showcase our capabilities, absorb emerging thinking, and explore new collaborations that advance patient impact.
“We are excited to join the World Orphan Drug Congress as both learners and contributors. The rare disease field continues to evolve at a rapid pace, from gene and cell therapies to novel evidence strategies and access models. Our aim is to bring Siron Clinical’s translational expertise to the table, to listen deeply and to form partnerships that translate innovation into real patient benefit. This Congress offers everything we need: scientific rigor, strategic dialogue, and ecosystem alignment.”
Jan Balemans – Siron Clinical CEO
What to Expect at This Year’s WODC 2025
The WODC 2025 agenda is notably comprehensive and multi‑track, reflecting the complexity of orphan drug development and the full ecosystem supporting it.
The Congress brings together leaders across the rare disease ecosystem to explore innovations in treatment, policy, diagnostics, and commercialization. Every theme is rooted in accelerating access and improving outcomes for rare disease patients.
Key Themes & Highlights
While the full agenda covers many topics, certain consistent themes emerge:
- Regulatory & HTA policy in Europe, multiple panels examine Europe’s life science strategy, EU HTA implementation, and joint clinical assessment for orphan medicines.
- Access, Pricing & Reimbursement sessions explore pricing models, reimbursement in different European markets, and access challenges for advanced therapies.
- Real-World Evidence & Data Innovation panels focus on applying RWE, registries, patient data, and advanced analytics in rare diseases.
FAQs: World Orphan Drug Congress Europe 2025
Q1: Why is Siron Clinical attending the World Orphan Drug Congress 2025?
Siron Clinical is committed to advancing research in complex, underserved areas like rare diseases. WODC 2025 provides a strategic platform for us to engage with biotech innovators, regulators, and advocacy leaders shaping the future of orphan drug development.
Q2: What does Siron Clinical bring to rare disease trials?
With over 25 years of experience and a proven Customizable FSP model, Siron Clinical supports sponsors in managing rare disease trials with precision, flexibility, and regional expertise across Europe, Israel, and Turkey, where trial logistics can be especially complex.
Q3: How can I meet with the Siron team at the event?
We’ll be exhibiting on-site and available for scheduled meetings throughout the Congress. To request a time or connect in advance, please reach out via our website.
If you’re navigating regulatory complexity, planning a rare disease trial, or exploring flexible CRO support, our team would welcome the opportunity to talk we’ll be at stand number 10.118.
Schedule a meeting with Siron Clinical in Amsterdam to see how our experience can support yours.
0 Comments